FDA Inspection
Pharmachemie B.V. dba Teva PharmachemiePharmachemie B.V. dba Teva Pharmachemie – FDA Inspection, Jun 28, 2013
Record Details
This FDA Inspection record concerns Pharmachemie B.V. dba Teva Pharmachemie, with an inspection on June 28, 2013, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- June 28, 2013
- Product Type
- Drugs
View Company Profile
ID · 218a1564-f80e-4501-a70b-a796075d2685
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 843559
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
1- 21 CFR 211.100(a)Absence of Written Procedures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Pharmachemie B.V. dba Teva Pharmachemie
6| Date | Classification | Office | Project area |
|---|---|---|---|
| October 17, 2024 | VAI | Drug Quality Assurance | |
| September 9, 2021 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 17, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 6, 2016 | Not classified | Office of Inspections and Investigations | |
| May 29, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Pharmachemie B.V. dba Teva Pharmachemie
- FDA Inspection 1306540 - 2024-10-17
- FDA Inspection 1240527 - 2021-09-09
- FDA Inspection 1092106 - 2019-05-17
- FDA Inspection 1000598 - 2016-12-06
- FDA Inspection 941457 - 2015-05-29
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.